Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia The purpose of this study is to determine the maximum tolerated duration and schedule of oral VORINOSTAT in addition to low dose cytarabine in the treatment of Intermediate-2 and High risk...

• Country France
• organs None
• Specialty None

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide This project is a framework for developing new therapeutic strategies for acute myeloid leukemia(AML)based immunotherapy. the role of NK cells was demonstrated in AML and especially GVL e...

• Country None
• organs None
• Specialty None

A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients This study is a phase Ib add-on study of the combination of LDE255 to azacitidine in patients without marrow response after at least 6 cycles of azacitidine.

• Country None
• organs None
• Specialty None